ECONSAP

Research Group on Health Economics in Primary Care

Multidisciplinary group composed of 21 researchers, six general practitioners (3 of them are also doctors in medicine), a peditrian, two practitioner, nurses, five doctors in psychology, four doctors in pharmacy, two pharmacy graduates and a doctor in psychiatry. The group originated in 1999 under the name GRAPISAM Group (Research Group in Primary Care and Mental Health) with the development of the DAPGA study that was carried out in the Mental Health Center of Gavà and the ABS Bartolomé Fabrés Anglada of Gavà. As a result of that first collaboration, others emerged, such as the ETAPS, FIBROQOL and PRODEFAR studies, which focused mainly on the evaluation of interventions aimed at the management of mental illnesses in primary care, always with a focus on health economics. In recent years, the group has grown, becoming more multidisciplinary, expanding the focus of research and increasingly specializing in the economic evaluation of health in primary care, including the evaluation of the economic impact of diseases (eg COSTDEP), the cost-effectiveness of preventive interventions (eg PREDICTD-CCRT), the cost-effectiveness of pharmacological treatments (eg INFAP) and non-pharmacological treatments (eg EUDAIMON), the cost of non-adherence and the impact of the introduction of health policies (eg NO-Iniciadores), etc. In addition, although the study of mental illnesses is still one of the main focuses of the group, the research has been extended to other pathologies, such as the management of chronic pain and fibromyalgia (eg Fibromyalgia subtypes and EUDAIMON) or multi-risk prevention (eg Econ-EIRA3). The group complements the use of clinical trials and economic evaluations with other study designs that allow it to better understand the difficulties of managing pathologies in primary care and the efficiency of treatments, such as psychometric analysis (WHODAS 2.0, CERQ, FFMQ, MISCI, etc.), qualitative research (eg, PREDICT-EVAL), systematic reviews (eg EIRA2), and epidemiological studies based on the secondary exploitation of large databases, such as SIDIAP, all within the framework of research in the field of primary care. This evolution has given way to the Research Group on Health Economics in Primary Care (ECONSAP). The main objectives of the group are to improve the quality and efficiency of mental pathologies and chronic physical diseases? care in Primary Care - including prevention and pharmacological and non-pharmacological treatment -, to assess the cost of diseases and patients? behavior and to develop innovative and multidisciplinary interventions in the area of Primary Care from a multidisciplinary point of view.

Group projects

PI: Rubio Valera, Maria. Avaluació de l'efectivitat i cost-efectivitat de la intervenció d'Adherència Inicial a la Medicació (IMA): Assaig controlat aleatoritzat per conglomerats i model econòmic (IMA-cRCT). Funding: Fundació per a la recerca i la docència Sant Joan de Déu (FSJD). Duration: 2021 - 2023

PI: Luciano Devis, Juan Vicente. Coste-utilidad y efectos fisiológicos de la Terapia de Aceptación y Compromiso y la Activación Conductual en pacientes con dolor crónico y depresión mayor comórbida (Proyecto IMPACT). Funding: Instituto de Salud Carlos III. Duration: 2020 - 2022

PI: Vicens Pons, Enric. Cohorte DESVELA. Análisis del papel de las aptitudes personales como DEterminantes de la incidencia de morbilidad, eStilos de vida, calidad de Vida, uso de sErvicios y mortaLidAd.. Funding: Instituto de Salud Carlos III. Duration: 2020 - 2022

PI: Rubio Valera, Maria. Pilot d'una intervenció complexa per millorar la iniciació al tractament farmacològic. Funding: Fundació per a la recerca i la docència Sant Joan de Déu (FSJD). Duration: 2020 - 2022

PI: Mendive Arbeloa, Juan Manuel. Developing, implementing and evaluating a clinical care pathway for NASH primary care patients: a multi-centre study. Funding: Gilead Sciences, S.L.U. Duration: 2020 - 2022

PI: Rubio Valera, Maria. El problema de la no iniciación pediátrica: Evaluación con métodos mixtos. Funding: Instituto de Salud Carlos III. Duration: 2020 - 2022

The group participates in the following projects

PI: Bellon Saameño, Juan Angel. Prevención de la ansiedad y depresión por evaluación de riesgos: ensayo controlado aleatorio (El Estudio PANDORA). Funding: Instituto de Salud Carlos III. Duration: 2022 - 2024

PI: Aznar Lou, Ignacio. The impact of the COVID-19 pandemic and its restrictions on chronification of benzodiazepine use. Funding: Fundació per a la recerca i la docència Sant Joan de Déu (FSJD). Duration: 2022 - 2024

PI: Moreno Peral, Patricia. Efectividad de una intervención personalizada a través de internet basada en un algoritmo de riesgo para la prevención universal de la ansiedad: ensayo aleatorio controlado. El estudio prevANS.. Funding: Ministerio de Ciencia e Innovación . Duration: 2021 - 2024

PI: Mendive Arbeloa, Juan Manuel. Prevención de la depresión a través de una intervención personalizada basada en TICs, algoritmos predictivos de riesgo, y DSS para pacientes y médicos de familia: El estudio e-predictD. Funding: ICS - Institut Català de la Salut. Duration: 2020 - 2022

The group participates in the following publications

Carbonell C, Rubio M, Marqués S, Peñarrubia MT, Gil MM, Pasarín MI, Parody E, Aznar I. Pediatric Medication Non-Initiation in Spain. Pediatrics. 2022;1(149):e2020034371-e202003437. PMID:34957504. IF: 7,124.

Gil-Girbau M, Peñarrubia-Maria MT, Carbonell-Simeón D, Rodríguez-Ferraz B, Contaldo SF, Iglesias-González M, Fernández-Vergel R, Blanco-García E, Baladon-Higuera L, Serrano-Blanco A, Rubio-Valera M. Assessment of a Primary Support Program: family physicians and mental health professionals' perspective. Fam Pract. 2022 Mar; doi:10.1093/fampra/cmac013. Epub 2022 Mar 04. PMID:35244164. IF: 2,267.

Irazoki A, Martinez-Vicente M, Aparicio P, Aris C, Alibakhshi E, Rubio-Valera M, Castellanos J, Lores L, Palacín M, Gumà A, Zorzano A, Sebastián D. Coordination of mitochondrial and lysosomal homeostasis mitigates inflammation and muscle atrophy during aging. Aging Cell. 2022 Apr; 21(4):e13583. doi:10.1111/acel.13583. Epub 2022 Mar 09. pmc:PMC9009131. PMID:35263007. IF: 9,304.

López-Del-Hoyo Y, Monreal-Bartolomé A, Aisa P, Pérez-Aranda A, Plana C, Poblador JA, Casterad J, García-Campayo J, Montero-Marin J. The Gambling Habits of University Students in Aragon, Spain: A Cross-Sectional Study. Int J Environ Res Public Health. 2022 04; 19(8). doi:10.3390/ijerph19084553. Epub 2022 Apr 09. pmc:PMC9024798. PMID:35457421. IF: 2,849.

Riba F, Guarner-Argente C, Solanes M, Francia E, Garcia-Iglesias P, Machlab S, Mascort J, Mendive JM, Ortiz J, Calvet X. . Gastroenterol Hepatol. 2022 Mar; doi:10.1016/j.gastrohep.2022.03.004. Epub 2022 Mar 09. PMID:35278501. IF: 2,102.

Sánchez-Viñas A, Corral-Partearroyo C, Gil-Girbau M, Peñarrubia-María MT, Gallardo-González C, Olmos-Palenzuela MD, Aznar-Lou I, Serrano-Blanco A, Rubio-Valera M. Effectiveness and cost-effectiveness of an?intervention to improve?Initial Medication Adherence?to treatments for cardiovascular diseases and diabetes in primary care: study protocol for a pragmatic cluster randomised controlled trial and economic model (the IMA-cRCT study). BMC Prim Care. 2022 07; 23(1):170. doi:10.1186/s12875-022-01727-6. Epub 2022 Jul 05. PMID:35790915. IF:2.634.

Awards

Premi Sanitat Baix Llobregat 2021 a la Mejor Publicación en el ámbito de Atención Primaria. Health Soc Care Community 2021; 00: 1-9 Article DOI: 10.1111/hsc.13431. Non-initiation of prescribed medication from a Spanish health professionals? perspective: a qualitative exploration based on Grounded Theory. Peñarrubia M, Gil M, Gallardo M, Aznar I, Serrano A, Mendive J, Rubio M.

Indicators

Indicator

2021

Researchers with PhD

10

Total number of projects in which group members have participated

11

Total number of projects in which the PI of the project has belonged to the group

7

Total Funding

630.885,79€

Scientific publications in indexed journals

5

Total Impact factor

26,28

Nº of articles in Q1 journals

2

Q1 IF

16,428

Nº of articles in Q2 journals

3

Q2 IF

9,528

Anar a l'inici